共 50 条
- [1] Qualitative and psychometric evaluation of the PROMIS®-Fatigue SF-7a scale to assess fatigue in patients with moderately to severely active inflammatory bowel disease [J]. Journal of Patient-Reported Outcomes, 7
- [8] Upadacitinib improves symptomatic responses in patients with moderately to severely active Crohn's disease [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : II000 - I1001